Stock Chart
Stock Chart
-
Previous Close
-
Open1.61
-
Bid
-
Ask
-
Day's Range1.4 - 1.66
-
52 week Range-
-
Volume4537375
-
Avg. Volume
-
Market Cap
-
Beta (5Y Monthly)
-
PE Ratio (TTM)
-
EPS (TTM)
-
Earnings Date
-
Forward Dividend & Yield
-
Ex-Dividend Date
-
1y Target Est
KEEP ME INFORMED ON SNGX UPDATES
SNGX Performance
-
5 Day0%1 Month0%3 Month0%YTD0%1 Year0%
SNGX on Twitter
-
Sat, Mar 6, 2:23 pm
-
Sat, Mar 6, 1:47 pm
-
Sat, Mar 6, 8:18 am
-
Sat, Mar 6, 3:04 am
-
Sat, Mar 6, 1:46 am
-
Fri, Mar 5, 5:19 pm
-
Fri, Mar 5, 5:16 pm
-
Fri, Mar 5, 5:16 pm
-
Fri, Mar 5, 5:16 pm
-
Fri, Mar 5, 5:13 pm
-
Fri, Mar 5, 5:13 pm
SNGX on iHub
-
Fri, Mar 5, 2:09 pm
-
Fri, Mar 5, 1:49 pm
-
Fri, Mar 5, 7:07 am
-
Fri, Mar 5, 6:34 am
-
Thu, Mar 4, 6:02 pm
-
Thu, Mar 4, 7:52 am
-
Thu, Mar 4, 7:34 am
-
Thu, Mar 4, 7:20 am
-
Fri, Feb 26, 7:28 pm
-
Fri, Feb 26, 2:58 pm
-
Fri, Feb 26, 2:54 pm
-
Thu, Feb 25, 2:52 pm
-
Thu, Feb 25, 1:24 pm
-
Wed, Feb 24, 4:36 pm
-
Fri, Feb 12, 8:37 pm
-
Fri, Feb 12, 7:53 pm
-
Fri, Feb 12, 7:49 pm
-
Fri, Feb 12, 3:32 pm
-
Fri, Feb 12, 9:48 am
-
Fri, Feb 12, 8:13 am
-
Fri, Feb 12, 7:53 am
-
Fri, Feb 12, 7:50 am
-
Fri, Feb 12, 7:50 am
-
Fri, Feb 12, 7:46 am
-
Fri, Feb 12, 7:43 am
-
Fri, Feb 12, 7:43 am
-
Fri, Feb 12, 7:41 am
-
Thu, Feb 11, 6:32 pm
-
Thu, Feb 11, 6:28 pm
-
Thu, Feb 11, 3:27 pm
-
Thu, Feb 11, 1:59 pm
-
Thu, Feb 11, 11:28 am
-
Thu, Feb 11, 11:03 am
-
Thu, Feb 11, 10:54 am
-
Thu, Feb 11, 10:45 am
-
Tue, Feb 9, 12:51 pm
-
Tue, Feb 9, 12:23 pm
-
Mon, Feb 8, 6:24 pm
-
Thu, Feb 4, 9:59 am
-
Tue, Feb 2, 1:48 pm
-
Thu, Jan 28, 1:40 pm
-
Thu, Jan 28, 12:46 pm
-
Thu, Jan 28, 12:40 pm
-
Thu, Jan 28, 12:33 pm
-
Thu, Jan 28, 12:26 pm
-
Thu, Jan 28, 12:23 pm
-
Thu, Jan 28, 12:18 pm
-
Thu, Jan 28, 12:17 pm
-
Wed, Jan 27, 3:02 pm
-
Wed, Jan 27, 2:20 pm
SNGX News
-
Thu, Mar 4, 8:12 am
The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company
-
Thu, Mar 4, 7:00 am
Soligenix Announces Positive Progress in the Pre-clinical Development of its COVID-19 Vaccine
-
Wed, Feb 24, 7:00 am
Soligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update Letter
-
Tue, Feb 23, 8:30 am
Soligenix is Ready for Commercialization of SGX301 (HyBryte(TM)); FDA Has Approval Process on Fast Track
-
Thu, Feb 11, 7:00 am
Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference
-
Tue, Feb 9, 8:30 am
Soligenix's Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301
-
Mon, Feb 1, 7:00 am
Soligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma
-
Thu, Jan 28, 6:51 am
SNGX: Provides Update on SGX301 Commercialization Plan…
-
Mon, Jan 25, 8:30 am
Soligenix Poised to Announce US Commercialization Plans of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma
-
Tue, Jan 19, 7:00 am
Soligenix Announces Investor Webcast Event: U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma
-
Thu, Jan 7, 7:00 am
Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma
-
Mon, Dec 28, 7:00 am
Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development
-
Wed, Dec 23, 4:50 am
SNGX: Phase 3 Trial of SGX942 Does Not Meet Primary Endpoint…
-
Tue, Dec 22, 7:45 am
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
-
Tue, Dec 22, 6:30 am
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
-
Wed, Dec 16, 9:00 am
Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing
-
Tue, Dec 8, 8:00 am
Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine
-
Tue, Nov 17, 8:00 am
Pfizer and Moderna COVID-19 Vaccine Candidates Are Promising, but Soligenix's Civax (TM) May Be a Better Alternative
-
Mon, Nov 16, 6:12 am
SNGX: One Positive Phase 3 Clinical Trial; One More to Readout Before End of 2020…
-
Thu, Nov 12, 8:46 am
How Much Did Soligenix's(NASDAQ:SNGX) Shareholders Earn From Share Price Movements Over The Last Five Years?
Copyright © 2012. 007 Stock Chat, LLC